These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3980073)

  • 1. Permeability-increasing ability of PAF-acether in rat skin.
    Gerdin B; Lundberg C; Smedegøard G
    Inflammation; 1985 Mar; 9(1):107-12. PubMed ID: 3980073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory effects of platelet activating factor (PAF) in equine skin.
    Foster AP; Cunningham FM; Lees P
    Equine Vet J; 1992 May; 24(3):208-14. PubMed ID: 1606934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic properties of LTB4 and paf-acether in vivo in human skin.
    Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
    J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of platelet-activating factor in inflammatory exudate.
    Oh-ishi S; Imai Y; Hayashi M
    J Lipid Mediat; 1992; 5(2):115-20. PubMed ID: 1525350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats.
    Lima MC; Martins MA; Perez SA; Silva PM; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1991 May; 197(2-3):201-7. PubMed ID: 1680710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor and the vascular effects of zymosan in rats.
    Damas J; Remacle-Volon G; Bourdon V
    Eur J Pharmacol; 1993 Feb; 231(2):231-6. PubMed ID: 8453979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
    Ueno A; Tokumasu T; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
    Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
    J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
    Björk J; Smedegård G
    Eur J Pharmacol; 1983 Dec; 96(1-2):87-94. PubMed ID: 6662199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z; Wolf MB
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
    Morley J; Page CP; Paul W
    Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig.
    Evans TW; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Clin Sci (Lond); 1989 May; 76(5):479-85. PubMed ID: 2721114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
    Stock EL; Roth SI; Kim ED; Walsh MK; Thamman R
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.